𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitomycin C plus 5-fluorouracil versus plasmapheresis and the same chemotherapy in metastatic colorectal cancer: A prospective randomized trial

✍ Scribed by J. -H. Beyer; R. Bätge; W. Rauschning; P. Schuff-Werner; H. Rauschecker; H. -J. Peiper

Book ID
112785593
Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
131 KB
Volume
111
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metastatic colorectal carcinoma: A prosp
Metastatic colorectal carcinoma: A prospective randomized trial of Methyl-CCNU, 5-fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-strep)
✍ Nancy Kemeny; Alan Yagoda; David Braun Jr. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

A Prospective Randomized Trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and Vincristine (MOF) Versus MOF Plus Streptozotocin (MOF-Strep) A prospective randomized trial evaluated semustine (Methyl CCNU) 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep) in 75 patients

Prospective randomized reappraisal of 5-
Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma a comparative trial with 6-thioguanine
✍ Cary A. Presant; Alex E. Denes; Charlene Liu; Alfred A. Bartolucci; The Southeas 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

In order to redefine the effectiveness of 5-fluorouracil (5-FU) as palliative therapy in patients with metastatic colorectal carcinoma, and to compare the effectiveness of 6-thioguanine (6-TG) with that of 5-FU, we studied 176 patients with metastatic colorectal carcinoma in a randomized prospective